Biodesix to Participate in the 2024 RBCCM Global Healthcare

Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1x1...

Related Keywords

New York , United States , Scott Hutton , Biodesix Inc , Nasdaq , Chief Executive Officer , Healthcare Conference , Chat Date , Chat Time , Intercontinental New York Barclay , Nodify Lung , Nodule Risk Assessment , Private Securities Litigation Reform Act , Risk Factors , Markets ,